Page 9 - Alpha Da News Today

/PRNewswire/ -- Alpha Tau Medical (Nasdaq: DRTS) (Nasdaq: DRTSW), the developer of the pioneering alpha-radiation cancer therapy Alpha DaRT™, announced today...

Medical device maker Alpha Tau (DRTS) saw its stock rally 17% on Thursday after several days of decline. Shares of DRTS opened at $4.89

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

Zacks Investment Research upgraded shares of Alpha Tau Medical (NASDAQ:DRTS – Get Rating) from a sell rating to a hold rating in a report published on Thursday, Zacks.com reports. According to Zacks, “Alpha Tau Medical Ltd. is a medical device company. It focuses on research, development, and potential commercialization of the Alpha DaRT for the […]

Penumbra (NYSE:PEN – Get Rating) and Alpha Tau Medical (NASDAQ:DRTS – Get Rating) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, earnings, profitability, analyst recommendations, risk and institutional ownership. Insider and Institutional Ownership 79.4% of Penumbra shares are held […]

Alpha Tau Medical (NASDAQ:DRTS – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Thursday, Zacks.com reports. According to Zacks, “Alpha Tau Medical Ltd. is a medical device company. It focuses on research, development, and potential commercialization of the Alpha DaRT for […]

Equities Research Analysts’ downgrades for Thursday, April 21st: ABB (NYSE:ABB) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy rating. Advanced Energy Industries (NASDAQ:AEIS) was downgraded by analysts at StockNews.com from a buy rating to a hold rating. Boston Scientific (NYSE:BSX) was downgraded by analysts at StockNews.com from a buy rating […]

Medtech Alpha Tau Medical (DRTS) stock slid 12% Friday after rallying 20% in the previous session

Several analysts have recently updated their ratings and price targets for Alpha Tau Medical (NASDAQ: DRTS): 4/15/2022 – Alpha Tau Medical was upgraded by analysts at Zacks Investment Research from a “sell” rating to a “hold” rating. According to Zacks, “Alpha Tau Medical Ltd. is a medical device company. It focuses on research, development, and […]

Alpha Tau Medical (DRTS) is waiting for FDA feedback to initiate a US pivotal trial in 1H-2022. Click here to know about DRTS' trials, financials and risks.